Literature DB >> 423190

Kojic amine--a novel gamma-aminobutyric acid analogue.

J G Atkinson, Y Girard, J Rokach, C S Rooney, C S McFarlane, A Rackham, N N Share.   

Abstract

A series of compounds containing the 3-hydroxy-4H-pyran-4-one nucleus has been synthesized and tested as potential skeletal muscle relaxants. Reduction of 2-(azidomethyl)-5-hydroxy-4H-pyran-4-one (4) with HBr in HOAc--phenol yielded 2-(aminomethyl)-5-hydroxy-4H-pyran-4-one (kojic amine, 3) in 81% yield. Reaction of 2-[(tosyloxy)-methyl]-5-(benzyloxy)-4H-pyran-4-one (5) with NH3 gave a 40% yield of the O-benzyl ether of kojic amine, which was N-acylated with a series of carbobenzyloxy-protected amino acids. Complete deprotection with HBr--HOAc gave the following amino acid amides of kojic amine: glycyl (23), alpha-alanyl (24), beta-alanyl (25), gamma-aminobutyryl (26), and glycylglycyl (27). Among the analogues of kojic amine prepared was a series of one-carbon homologues: 2-[(methylamino)methyl]-5-hydroxy-4H-pyran-4-one (7a), 2-(1-aminoethyl)-5-hydroxy-4H-pyran-4-one (8), 6-(aminomethyl)-3-hydroxy-2-methyl-4H-pyran-4-one (12), and 2-(2-aminoethyl)-5-hydroxy-4H-pyran-4-one (16). Kojic amine (3) has been found to possess certain of the properties to be expected in a gamma-aminobutyric acid mimetic agent, notably skeletal muscle relaxant activity. In the chronic spinal cat preparation, ED70 values for reduction of flexor spasms of 2.2 and 4.0 mg/kg by iv and po routes of administration, respectively, were observed for kojic amine, which was the most potent of the various hydroxypyrone derivatives investigated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 423190     DOI: 10.1021/jm00187a022

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT).

Authors:  Scott T Harrison; Michael S Poslusney; James J Mulhearn; Zhijian Zhao; Nathan R Kett; Jeffrey W Schubert; Jeffrey Y Melamed; Timothy J Allison; Sangita B Patel; John M Sanders; Sujata Sharma; Robert F Smith; Dawn L Hall; Ronald G Robinson; Nancy A Sachs; Pete H Hutson; Scott E Wolkenberg; James C Barrow
Journal:  ACS Med Chem Lett       Date:  2015-01-26       Impact factor: 4.345

2.  Pharmacological analysis of the central cardiovascular effects of four GABA analogues.

Authors:  P Bousquet; J Feldman; R Bloch; J Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-04       Impact factor: 3.000

Review 3.  GABA agonists. Development and interactions with the GABA receptor complex.

Authors:  P Krogsgaard-Larsen; E Falch
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.